See more : Elinoil Hellenic Petroleum Company S.A. (ELIN.AT) Income Statement Analysis – Financial Results
Complete financial analysis of ENvizion Medical Ltd. (ENVM.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ENvizion Medical Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Delta Plus Group (DLTA.PA) Income Statement Analysis – Financial Results
- Univentures Public Company Limited (UV.BK) Income Statement Analysis – Financial Results
- Luxi Chemical Group Co., Ltd. (000830.SZ) Income Statement Analysis – Financial Results
- GUD Holdings Limited (GUDHF) Income Statement Analysis – Financial Results
- Vitro, S.A.B. de C.V. (VITROA.MX) Income Statement Analysis – Financial Results
ENvizion Medical Ltd. (ENVM.TA)
About ENvizion Medical Ltd.
ENvizion Medical Ltd. operates as a medical device company. It offers ENvue feeding tube placement system that utilizes the methods of navigation, integrated sensors, and body mapping to provide feeding tube placement. The company was founded in 2017 and is based in Tel Aviv-Yafo, Israel.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 2.13M | 1.67M | 883.88K | 0.00 | 0.00 |
| Cost of Revenue | 2.78M | 1.50M | 1.89M | 680.30K | 0.00 |
| Gross Profit | -646.98K | 170.68K | -1.01M | -680.30K | 0.00 |
| Gross Profit Ratio | -30.36% | 10.22% | -114.18% | 0.00% | 0.00% |
| Research & Development | 8.21M | 6.23M | 5.67M | 7.08M | 6.79M |
| General & Administrative | 10.02M | 8.84M | 4.86M | 2.97M | 2.06M |
| Selling & Marketing | 10.17M | 4.93M | 2.86M | 763.18K | 56.09K |
| SG&A | 20.19M | 13.77M | 7.72M | 3.73M | 2.11M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 26.00M | 22.11M | 16.13M | 10.92M | 8.90M |
| Cost & Expenses | 28.78M | 23.61M | 18.02M | 11.60M | 8.90M |
| Interest Income | 158.23K | 34.14K | 22.50K | 13.81K | 93.49K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 443.04K | 189.30K | 318.20K | 245.19K | 235.60K |
| EBITDA | -28.69M | -19.64M | -14.08M | -11.24M | -8.67M |
| EBITDA Ratio | -1,346.53% | -1,176.39% | -1,593.09% | 0.00% | 0.00% |
| Operating Income | -29.14M | -19.83M | -14.40M | -11.49M | -8.90M |
| Operating Income Ratio | -1,367.33% | -1,187.73% | -1,629.09% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.33M | -2.14M | -2.76M | -120.87K | -93.49K |
| Income Before Tax | -26.81M | -21.97M | -17.16M | -11.61M | -9.00M |
| Income Before Tax Ratio | -1,258.09% | -1,316.17% | -1,941.09% | 0.00% | 0.00% |
| Income Tax Expense | 24.61K | 31.03K | 0.00 | 0.00 | 0.00 |
| Net Income | -26.83M | -22.01M | -17.16M | -11.61M | -9.00M |
| Net Income Ratio | -1,259.24% | -1,318.03% | -1,941.09% | 0.00% | 0.00% |
| EPS | -10.23 | -11.63 | -12.18 | -10.10 | -11.38 |
| EPS Diluted | -10.23 | -11.63 | -12.18 | -10.10 | -11.38 |
| Weighted Avg Shares Out | 2.62M | 1.89M | 1.41M | 1.15M | 790.68K |
| Weighted Avg Shares Out (Dil) | 2.62M | 1.89M | 1.41M | 1.15M | 790.69K |
Source: https://incomestatements.info
Category: Stock Reports